Selegiline Transdermal System for the Treatment of Major Depressive Disorder: An 8-Week, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Trial
Year: 2006
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.4088/jcp.v67n0905
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1970922316
